{"id":"W3211510829","doi":"10.1182/blood-2021-150573","title":"A Phase II Study of 5-Azacytidine (AZA) and Venetoclax As Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Myeloid leukemia; Complete remission; Medicine; Azacitidine; Internal medicine; Leukemia; Maintenance therapy; Cytarabine; Oncology; Chemotherapy; Chemistry; Chronic lymphocytic leukemia","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002248889,0.00113095,0.00193877,0.0005053043,0.0005651297,0.0008488473,0.001101039,0.001214989,0.00317104],"category_scores_gemma":[0.001200145,0.0006828146,0.0009348472,0.000493469,0.001135512,0.000749108,0.0004183988,0.00336258,0.0006287819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006722132,"about_ca_system_score_gemma":0.001782905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00110607,"about_ca_topic_score_gemma":0.001550408,"domain_scores_codex":[0.9991979,0.0004376612,0.0000449278,0.0001231183,0.0000582749,0.0001381326],"domain_scores_gemma":[0.9986933,0.0002454201,0.0001758896,0.0001415638,0.00006518581,0.0006787112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7927231,0.1287626,0.008179515,0.0003571299,0.0005211171,0.0001893243,0.0002538293,0.0008563714,0.03019425,0.000176361,0.0008515713,0.03693495],"study_design_scores_gemma":[0.4998438,0.4890502,0.007568073,0.00001243215,0.0002044868,0.0001140812,0.00003237776,0.000370959,0.001895424,0.00005335051,0.0008432117,0.00001157497],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945776,0.0007368129,0.0002862817,0.0001535047,0.00006849014,0.0030968,0.0003550839,0.00003782623,0.0006874877],"genre_scores_gemma":[0.9914827,0.0007368097,0.001523455,0.0003964308,0.0002161435,0.003224972,0.001052205,0.00001364676,0.001353561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00317104,"threshold_uncertainty_score":0.01189339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0125927677770187,"score_gpt":0.2914724844513646,"score_spread":0.2788797166743459,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}